PHGE
USDBiomX Inc. COmmon Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$0.460
고가
$0.463
저가
$0.435
거래량
0.13M
기업 기본 정보
시가총액
11.5M
산업
생명공학
국가
Israel
거래 통계
평균 거래량
0.13M
거래소
ASE
통화
USD
52주 범위
관련 뉴스
BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference
NESS ZIONA, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic
HC Wainwright & Co. Maintains Buy on BiomX, Lowers Price Target to $15
HC Wainwright & Co. analyst Joseph Pantginis maintains BiomX with a Buy and lowers the price target from $21 to $15.
BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates
In March 2025, BiomX announced positive topline results of the phase 2 trial evaluating BX211 for the treatment of diabetic foot osteomyelitis (DFO) BX004 Phase 2b study in Cystic Fibrosis (CF) on track to report
BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025
NESS ZIONA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic
관련 주식
ATXS
Astria Therapeutics Inc.
ACB
Aurora Cannabis Inc. Common Shares
OABIW
OmniAb Inc. Warrant
XOMAP
XOMA Royalty Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
SXTC
China SXT Pharmaceuticals Inc. Ordinary Shares
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기